Edition:
United States

Hybio Pharmaceutical Co Ltd (300199.SZ)

300199.SZ on Shenzhen Stock Exchange

16.50CNY
29 Mar 2017
Change (% chg)

¥-0.33 (-1.96%)
Prev Close
¥16.83
Open
¥16.86
Day's High
¥16.86
Day's Low
¥16.50
Volume
5,359,696
Avg. Vol
5,529,556
52-wk High
¥23.54
52-wk Low
¥15.80

Latest Key Developments (Source: Significant Developments)

Hybio Pharmaceutical to issue corporate bonds worth up to 1 bln yuan
Tuesday, 28 Feb 2017 12:48am EST 

Hybio Pharmaceutical Co Ltd <300199.SZ> : Says it plans to issue public corporate bonds worth up to 1 billion yuan in total, with a term of no more than 5 years .Says proceeds will be used for working capital supplement and loan repayment.  Full Article

Hybio Pharmaceutical sees FY 2016 net profit up 0 pct to 30 pct
Monday, 23 Jan 2017 12:45am EST 

Hybio Pharmaceutical Co., Ltd.<300199.SZ>: Sees net profit for FY 2016 to increase by 0 percent to 30 percent, or to be 305.3 million yuan to 396.9 million yuan . Says the net profit of FY 2015 was 305.3 million yuan .Comments that development of overseas market is the main reason for the forecast.  Full Article

Hybio Pharmaceutical's METHOD FOR SOLID PHASE SYNTHESIS OF LIRAGLUTIDE gets patent in EU
Tuesday, 27 Dec 2016 09:38pm EST 

Hybio Pharmaceutical Co., Ltd.<300199.SZ>:Says the co's METHOD FOR SOLID PHASE SYNTHESIS OF LIRAGLUTIDE received patent in Europe.  Full Article

Hybio Pharmaceutical raises 660 mln yuan via private placement
Thursday, 13 Oct 2016 10:09pm EDT 

Hybio Pharmaceutical Co Ltd <300199.SZ> :Says it issues 28.3 million new shares via private placement and raises about 660 million yuan in total.  Full Article

Hybio Pharmaceutical receives patent license
Monday, 26 Sep 2016 06:07am EDT 

Hybio Pharmaceutical <300199.SZ>:Says it received a patent license (No. ZL 2013 1 0425340.4), for a manufacturing method of sitagliptin and its intermediate.  Full Article

Hybio Pharmaceutical says 2016 H1 net profit to up 20~30 pct
Thursday, 14 Jul 2016 11:02pm EDT 

Hybio Pharmaceutical Co Ltd <300199.SZ>: Sees net profit for 2016 H1 to increase by 20 percent to 30 percent .Says the net profit of 2015 H1 was 89.7 million yuan.  Full Article

Hybio Pharmaceutical gets patent license
Wednesday, 29 Jun 2016 11:37pm EDT 

Hybio Pharmaceutical Co Ltd <300199.SZ>:Says it received a patent license for preparation method of peptide aldehyde.  Full Article

Hybio Pharmaceutical gets patent license
Tuesday, 28 Jun 2016 10:58pm EDT 

Hybio Pharmaceutical Co Ltd <300199.SZ>:Says it received a patent license for synthesis method of lisinopril.  Full Article

Hybio Pharmaceutical receives patent license
Thursday, 23 Jun 2016 10:25pm EDT 

Hybio Pharmaceutical Co., Ltd. <300199.SZ>:Says it receives a patent license (No. ZL 2014 1 0196509.8), for the manufacturing method of a nesiritide medicine.  Full Article

Hybio Pharmaceutical receives patent license
Wednesday, 1 Jun 2016 05:13am EDT 

Hybio Pharmaceutical <300199.SZ>: Says it received a patent license (No. ZL 2013 1 0631343.3), for a solid phase synthesis method of Orfamide A .Says the patent valid for 20 years since Nov. 29, 2013.  Full Article

More From Around the Web

BRIEF-Hybio Pharmaceutical to issue corporate bonds worth up to 1 bln yuan

* Says it plans to issue public corporate bonds worth up to 1 billion yuan in total, with a term of no more than 5 years